Literature DB >> 33329868

A Case of Severe Falciparum Malaria in a Returned Traveler.

Q J Low1, W K Lau2, T H Lim3, R A Lee4, S W Cheo5.   

Abstract

Primary care providers should be alert to travel-related infections. Around 10-40% of returning travelers from all destinations and 15-70% of travelers from tropical settings experience ill health, either overseas or upon returning home.1 A systematic approach concentrating on possible infections should be undertaken based on the patient's travel location, immunization history, presence of malaria chemoprophylaxis at the destination, other potential exposures, incubation period, and clinical presentation.2-3 The World Health Organization (WHO) website is constantly being updated on specific travel-related infections and recent geographical outbreaks. In this paper, we report a case of severe falciparum malaria in a returned traveler. © Academy of Family Physicians of Malaysia.

Entities:  

Keywords:  Cerebral malaria; fever; plasmodium falciparum; traveler

Year:  2020        PMID: 33329868      PMCID: PMC7735881     

Source DB:  PubMed          Journal:  Malays Fam Physician        ISSN: 1985-2274


  5 in total

Review 1.  Assessment of febrile illness in the returned traveller.

Authors:  Peter A Leggat
Journal:  Aust Fam Physician       Date:  2007-05

Review 2.  Approach to Fever in the Returning Traveler.

Authors:  Guy E Thwaites; Nicholas P J Day
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

3.  Impact of Travel-Related Health Impairments.

Authors: 
Journal:  J Travel Med       Date:  1997-06-01       Impact factor: 8.490

Review 4.  Fever in the Returning Traveler.

Authors:  Felicia A Scaggs Huang; Elizabeth Schlaudecker
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

5.  GeoSentinel surveillance of illness in returned travelers, 2007-2011.

Authors:  Karin Leder; Joseph Torresi; Michael D Libman; Jakob P Cramer; Francesco Castelli; Patricia Schlagenhauf; Annelies Wilder-Smith; Mary E Wilson; Jay S Keystone; Eli Schwartz; Elizabeth D Barnett; Frank von Sonnenburg; John S Brownstein; Allen C Cheng; Mark J Sotir; Douglas H Esposito; David O Freedman
Journal:  Ann Intern Med       Date:  2013-03-19       Impact factor: 25.391

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.